details can be found via gov.uk
FDA Approval Status: Approved: September 2019 Indication: Type 2 diabetes management NOT approved for weight loss specifically Manufacturer: Novo Nordisk Available Doses: 3 mg (starting dose) 7 mg (maintenance dose) 14 mg (maximum dose) How Rybelsus Works: SNAC Technology: Rybelsus uses a compound called SNAC (salcaprozate sodium) to help semaglutide absorb through the stomach lining
Proposed pathways include modulation of multiple neurotransmitter systems (influencing serotonin, dopamine, norepinephrine, GABA, glutamate levels), possible involvement of NMDA receptors, alpha-1 adrenergic signaling (e.g., potentiating pineal acetyltransferase activity), inhibition of somatostatin release via dopaminergic routes, reduced ACTH/cortisol for stress buffering, and stimulated growth hormone or somatoliberin secretion
In the major trials these were the dominant adverse events, generally mild to moderate, and only a small minority stopped treatment because of them
Hyperlipidemia is a prevalent source of oxidative stress that has been shown to increase red cell fragility and induce hemolysis, though the extent to which it may induce chronic low-grade intravascular hemolysis in a G6PD-d model is uncertain 58,59
3-fluoromethcathinone, a structural analog of mephedrone, inhibits growth and induces cell cycle arrest in HT22 mouse hippocampal cells
